IL-10 is also highly expressed in CD4+ cells, CD8+ T cells, and regulatory T cells (Tregs) [12,13,14]. Historically, IL-10 has been thought to exert potent pro-tumor effects [15,16] mainly due to its immunosuppressive abilities [17,18]. The gene discussed is CD8A; the disease is neoplasm.